Pharmaceuticals & Biotechnology

BIO-PATH HOLDINGS, INC. CEO pay

Peter H. Nielsen, CEO, CFO President, Chairman, Director. Fiscal year 2023, as reported to the SEC.

Total compensation

$827K

$827,117 for fiscal 2023: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2024-10-28SEC accession number 0001558370-24-013752

In context

The median chief executive among 289 Pharmaceuticals & Biotechnology companies with under $100M in revenue was paid $2.3M. The middle half ranged from $933K to $4.3M.

Peter H. Nielsen's total is below that median.

See how your pay compares to BIO-PATH HOLDINGS, INC.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: BIO-PATH HOLDINGS, INC.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2023. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-11-01. Not financial, legal or compensation-consulting advice.